Andrew Stephenson
机构: Associate Professor of Surgery, Cleveland Clinic
每年引用次数
引用次数
引用: 18,378
H-指数: 68
I10-指数 : 166
出版物: 540
Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium
John S McGrath , J Aning
European Urology Open Science 19
2020
Management of poor-prognosis testicular germ cell tumors
AndrewJ Stephenson , Kiranpreet Khurana , TimothyD Gilligan
Indian Journal of Urology 26 ( 1) 108 -114
5
2010
Screening for urologic malignancies in primary care: pros, cons, and recommendations.
A. J Stephenson , L. Kuritzky , S. C Campbell
Cleveland Clinic Journal of Medicine 74 6 -14
9
2007
1617: Low Pretreatment Total Testosterone Levels are Associated with a Predominance of Pattern 4 Prostate Cancer at Prostatectomy and Risk of Biochemical Recurrence
Brian R Lane , Andew J Stephenson , Alwyn M Reuther , Michael W Kattan
The Journal of Urology 177 536 -536
1
2007
ROBOTIC PARTIAL NEPHRECTOMY: DIFFERENT APPROACHES FOR DIFFERENT CLINICAL SCENARIOS
RAKESH KHANNA , HUMBERTO K LAYDNER , RICCARDO AUTORINO , MICHAEL A WHITE
JOURNAL OF ENDOUROLOGY 24 A341 -A341
2010
THE UTILITY OF OUTCOME PREDICTION MODELS FOR PROSTATE CANCER THERAPY
ANDREW J STEPHENSON , MICHAEL W KATTAN
Comprehensive Textbook of Genitourinary Oncology 129 -129
2006
Comment on: Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer
AJ STEPHENSON , GJ BOSL , RJ MOTZER , DF BARJORIN
European urology 53 ( 5) 1086 -1088
2008
DOUBLE-STRANDED STRONG-STOP DNA AND HIV REVERSE TRANSCRIPTION
P LI , AJ STEPHENSON , LJ KUIPER , CJ BURRELL
JOURNAL OF CELLULAR BIOCHEMISTRY 32 -32
1993
Histopathologic features and clinical outcomes in 71 cases of bladder diverticula.
Donna E. Hansel , Drogo K. Montague , Andrew J. Stephenson , Steven C. Campbell
Archives of Pathology & Laboratory Medicine 133 ( 5) 791 -796
46
2009
Predicting disease progression in men with localized high risk prostate cancer undergoing radical prostatectomy.
Lamont Wilkins , Kasra Yousefi , Meera Chappidi , Chandana A. Reddy
Journal of Clinical Oncology 35 51 -51
2017
Prediction of pathological outcome at radical prostatectomy for MRI-ultrasound fusion prostate biopsy versus standard transrectal ultrasound guided prostate biopsy.
Hans Arora , Yaw A. Nyame , Ahmed El-Shafei , Onder Kara
Journal of Clinical Oncology 35 ( 6_suppl) 73 -73
2017
The effect of androgen deprivation therapy on prostate cancer-specific mortality in high-risk prostate cancer: Patients treated with low dose-rate brachytherapy without supplementary external beam radiotherapy.
Jay P. Ciezki , Chandana A. Reddy , Michael A. Weller , Rahul D. Tendulkar
Journal of Clinical Oncology 35 ( 6_suppl) e550 -e550
2017
OncotypeDx genomic scores independent of disease volume in men with favorable-risk prostate cancer.
Dominic C. Grimberg , Yaw A. Nyame , Daniel J. Greene , Karishma Gupta
Journal of Clinical Oncology 35 ( 6_suppl) 93 -93
2017
The effect of prostatectomy technique on genitourinary toxicity.
Jay P. Ciezki , Chandana A. Reddy , Georges-Pascal Haber , Jihad Kaouk
Journal of Clinical Oncology 35 100 -100
1
2017
Assessment of blood and tissue myeloid derived suppressor cells (MDSC), clinicopathologic factors, and treatment response in urothelial carcinoma (UC) patients (pts) undergoing surgery.
Moshe Chaim Ornstein , C. Marcela Diaz-Montero , Patricia A. Rayman , Paul Elson
Journal of Clinical Oncology 35 362 -362
1
2017
The impact of treatment delay from diagnosis to prostatectomy on the biochemical recurrence rate.
Sudhir Isharwal , Joseph Zabell , Ryan Kent Berglund , Andrew J. Stephenson
Journal of Clinical Oncology 35 34 -34
2017
Prognostic value of DLL3 expression and clinicopathologic features in small cell bladder cancer (SCBC).
Laura Saunders , Edward Kavalerchik , Scott Dylla , Sheila Bheddah
Journal of Clinical Oncology 35 382 -382
2
2017
Adjuvant enzalutamide (Enza) for men with high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).
Moshe Chaim Ornstein , Andrew J. Stephenson , Paul Elson , Allison Janine Tyler
Journal of Clinical Oncology 34 ( 15_suppl) 5071 -5071
2016
Evaluation of blood and tissue myeloid derived suppressor cells (MDSC), clinicopathologic factors, and pathologic response in urothelial carcinoma (UC).
Moshe Chaim Ornstein , C. Marcela Diaz-Montero , Pat A. Rayman , Paul Elson
Journal of Clinical Oncology 34
2016
Patient/treatment characteristics and prognostic factors in small-cell bladder cancer (SCBC).
Vadim S Koshkin , Hamid Emamekhoo , Paul Elson , Jesse McKenney
Journal of Clinical Oncology 34
2016